期刊文献+

顺铂预处理对CIK杀伤非霍奇金淋巴瘤细胞的影响 被引量:2

Cytotoxic effect of preconditioning with Cisplatin on CIK against non Hodgkin lymphoma cells
下载PDF
导出
摘要 目的探讨顺铂(DDP)预处理对细胞因子诱导的杀伤细胞(CIK)杀伤非霍奇金淋巴瘤细胞的影响。方法体外培养人类NHL细胞株Namalwa(Burkitt淋巴瘤细胞株)、SU—DHL-4(弥漫大B淋巴瘤细胞株)及CIK细胞,采用CFSE/PI双标法检测DDP预处理不同浓度、不同时间,CIK对非霍奇金淋巴瘤细胞的杀伤活性影响。应用SPSS 19.0统计学软件对数据进行统计学分析。结果体外诱导获得CIK细胞,随着DDP预处理浓度的增加,CIK细胞杀伤淋巴瘤细胞的活性随之增强,随着DDP预处理时间的延长,CIK细胞杀伤淋巴瘤细胞的活性亦增强。结论 DDP预处理淋巴瘤细胞后,CIK杀伤淋巴瘤细胞活性增强。 Objective To study the cytotoxic effect of Cisplatin pretreatment on cytokine induced killer (CIK) cells against non Hodgkin lymphoma cells.Methods Human NHL cell lines Namalwa (Burkitt lymphoma cell line),SU-DHL-4 (diffuse large B lymphoma cell line) and CIK cells were cultivated in vitro,CFSE/PI double labeling method was used to detect the cytotoxic effect of CIK after DDP pretreatment non-Hodgkin lymphoma cells at different concentration,different time.SPSS 19.0 software was used for statistical analysis.Results The CIK cells were cultured.With the increase of DDP precondition concentration,the cytotoxic effect of CIK increased.With the prolong of DDP precondition time,the cytotoxic effect of CIK increased.Conclusion Preconditioning non-Hodgkin lymphoma cells with DDP can enhance the killing effect of CIK.
出处 《中国医药导报》 CAS 2013年第25期12-14,共3页 China Medical Herald
关键词 顺铂 细胞因子诱导的杀伤细胞 非霍奇金淋巴瘤 杀伤活性 DDP CIK Non Hodgkin lymphoma cells Kill activity
  • 相关文献

参考文献12

二级参考文献96

共引文献153

同被引文献55

  • 1王家祥,郑树,刘秋亮.不同来源CIK细胞的体外扩增和杀伤活性的比较[J].第四军医大学学报,2005,26(7):616-618. 被引量:26
  • 2郭智,谭晓华,高锦,楼金星,刘晓东,何学鹏.CIK治疗耐药性非霍奇金淋巴瘤疗效观察[J].实用癌症杂志,2006,21(1):15-16. 被引量:29
  • 3Schmidt-Wolf IG,Negrin RS,Kiem HP,et al.Use of a SCID mouse/ human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity[J].J Exp Med,1991,174:139-149.
  • 4Linn YC,Lau SK,Liu BH,et al.Characterization of the recognition and functional heterogeneity exhibited by cytokine-induced killer cell subsets against acute myeloid leukaemia target cell[J].Immunology,2009,126:423-435.
  • 5Jiang J,Xu N,Wu C,et al.Treatment of advanced gastric cancer by chemotherapy combined with autologous cytokine-induced killer cells[J].Anticancer Res,2006,26:2237-2242.
  • 6Lu PH,Negrin RS.A novel population of expanded human CD3+ CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency[J].J Immunol,1994,153:1687-1696.
  • 7Mehta BA,Schmidt-Wolf IG,Weissman IL,et al.Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cells[J].Blood,1995,86:3493-3499.
  • 8Olson JA,Leveson-Gower DB,Gill S,et al.NK cells mediate reduction of GVHD by inhibiting activated,alloreactive T cells while retaining GVT effects[J].Blood,2010,115:4293-4301.
  • 9Zoll B,Lefterova P,Ebert O,et al.Modulation of cell surface markers on NK-like T lymphocytes by using IL-2,IL-7 or IL-12 in vitro stimulation[J].Cytokine,2000,12:1385-1390.
  • 10Zoll B,Lefterova P,Csipai M,et al.Generation of cytokine-induced killer cells using exogenous interleukin-2,-7 or-12[J].Cancer Immunol Immunother,1998,47:221-226.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部